New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, Myeloma4 December 2018
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risksConferences11 October 2018
Denosumab delays the time to first skeletal-related event in patients with myelomaConferences, Myeloma5 June 2017
MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, Myeloma24 June 2016
